BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aryal S, Skinner T, Bridges B, Weber JT. The Pathology of Parkinson's Disease and Potential Benefit of Dietary Polyphenols. Molecules 2020;25:E4382. [PMID: 32987656 DOI: 10.3390/molecules25194382] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Huang B, Hu G, Zong X, Yang S, He D, Gao X, Liu D. α-Cyperone protects dopaminergic neurons and inhibits neuroinflammation in LPS-induced Parkinson's disease rat model via activating Nrf2/HO-1 and suppressing NF-κB signaling pathway. Int Immunopharmacol 2023;115:109698. [PMID: 36634417 DOI: 10.1016/j.intimp.2023.109698] [Reference Citation Analysis]
2 Li L, Jin P, Guan Y, Luo M, Wang Y, He B, Li B, He K, Cao J, Huang C, Li J, Shen Z. Exploiting Polyphenol-Mediated Redox Reorientation in Cancer Therapy. Pharmaceuticals (Basel) 2022;15. [PMID: 36558995 DOI: 10.3390/ph15121540] [Reference Citation Analysis]
3 Shamilov AA, Olennikov DN, Pozdnyakov DI, Bubenchikova VN, Garsiya ER, Larskii MV. Caucasian Blueberry: Comparative Study of Phenolic Compounds and Neuroprotective and Antioxidant Potential of Vaccinium myrtillus and Vaccinium arctostaphylos Leaves. Life (Basel) 2022;12. [PMID: 36556444 DOI: 10.3390/life12122079] [Reference Citation Analysis]
4 Isgrò C, Spagnuolo L, Pannucci E, Mondello L, Santi L, Dugo L, Sardanelli AM. Rhus Coriaria L. Extract: Antioxidant Effect and Modulation of Bioenergetic Capacity in Fibroblasts from Parkinson’s Disease Patients and THP-1 Macrophages. IJMS 2022;23:12774. [DOI: 10.3390/ijms232112774] [Reference Citation Analysis]
5 Liu H, Deng B, Zhou H, Wu Z, Chen Y, Weng G, Zhu S, Xu J, Wang H, Zhou Z, Tan E, Wang Q. QEEG indices are associated with inflammatory and metabolic risk factors in Parkinson's disease dementia: An observational study. eClinicalMedicine 2022;52:101615. [DOI: 10.1016/j.eclinm.2022.101615] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Xu B, Chen J, Liu Y. Curcumin Interacts with α-Synuclein Condensates To Inhibit Amyloid Aggregation under Phase Separation. ACS Omega. [DOI: 10.1021/acsomega.2c03534] [Reference Citation Analysis]
7 Apiraksattayakul S, Pingaew R, Prachayasittikul V, Ruankham W, Jongwachirachai P, Songtawee N, Suwanjang W, Tantimongcolwat T, Prachayasittikul S, Prachayasittikul V, Phopin K. Neuroprotective Properties of Bis-Sulfonamide Derivatives Against 6-OHDA-Induced Parkinson's Model via Sirtuin 1 Activity and in silico Pharmacokinetic Properties. Front Mol Neurosci 2022;15:890838. [DOI: 10.3389/fnmol.2022.890838] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Okuyama S, Yoshimura M, Amakura Y, Nakajima M, Furukawa Y. Activation of Extracellular Signal-Regulated Kinase 2 and cAMP Response Element-Binding Protein in Cultured Neurons by the Macrocyclic Ellagitannin Oenothein B. NeuroSci 2022;3:387-394. [DOI: 10.3390/neurosci3030028] [Reference Citation Analysis]
9 Fu X, Wang J, Cai H, Jiang H, Jiang J, Chen H, Han S. Co-Application of C16 and Ang-1 Improves the Effects of Levodopa in Parkinson Disease Treatment. JIR 2022;Volume 15:3797-814. [DOI: 10.2147/jir.s368291] [Reference Citation Analysis]
10 do Nascimento TG, Paes-silva RP, da Luz MCL, Cabral PC, de Araújo Bezerra GK, Gomes ACB. Phase angle, muscle mass, and functionality in patients with Parkinson’s disease. Neurol Sci 2022;43:4203-4209. [DOI: 10.1007/s10072-022-05975-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Fanarioti E, Tsarouchi M, Vasilakopoulou PB, Chiou A, Karvelas M, Karathanos VT, Dermon CR. Brain polar phenol content, behavioural and neurochemical effects of Corinthian currant in a rotenone rat model of Parkinson's disease. Nutr Neurosci 2022;:1-15. [PMID: 35656969 DOI: 10.1080/1028415X.2022.2080792] [Reference Citation Analysis]
12 Xu B, Mo X, Chen J, Yu H, Liu Y. Myricetin Inhibits α-Synuclein Amyloid Aggregation by Delaying the Liquid-to-Solid Phase Transition. Chembiochem 2022;:e202200216. [PMID: 35657723 DOI: 10.1002/cbic.202200216] [Reference Citation Analysis]
13 Witucki Ł, Kurpik M, Jakubowski H, Szulc M, Łukasz Mikołajczak P, Jodynis-Liebert J, Kujawska M. Neuroprotective Effects of Cranberry Juice Treatment in a Rat Model of Parkinson's Disease. Nutrients 2022;14:2014. [PMID: 35631155 DOI: 10.3390/nu14102014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Rahimmi A, Tozandehjani S, Daraei M, Khademerfan M. The neuroprotective roles of Dietary Micronutrients on Parkinson’s disease: a review. Mol Biol Rep. [DOI: 10.1007/s11033-022-07345-w] [Reference Citation Analysis]
15 Fantacuzzi M, Amoroso R, Carradori S, De Filippis B. Resveratrol-based compounds and neurodegeneration: Recent insight in multitarget therapy. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114242] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Azizi Z, Majlessi N, Choopani S, Naghdi N. Neuroprotective effects of carvacrol against Alzheimer's disease and other neurodegenerative diseases: A review. Avicenna J Phytomed 2022;12:371-87. [PMID: 35782773 DOI: 10.22038/AJP.2022.19491] [Reference Citation Analysis]
17 Miao Q, Chai Z, Song L, Wang Q, Song G, Wang J, Yu J, Xiao B, Ma C. The neuroprotective effects and transdifferentiation of astrocytes into dopaminergic neurons of Ginkgolide K on Parkinson's disease mice. Journal of Neuroimmunology 2022. [DOI: 10.1016/j.jneuroim.2022.577806] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Prakash S, Carter WG. The Neuroprotective Effects of Cannabis-Derived Phytocannabinoids and Resveratrol in Parkinson's Disease: A Systematic Literature Review of Pre-Clinical Studies. Brain Sci 2021;11:1573. [PMID: 34942876 DOI: 10.3390/brainsci11121573] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
19 Fakhri S, Abdian S, Zarneshan SN, Akkol EK, Farzaei MH, Sobarzo-Sánchez E. Targeting Mitochondria by Plant Secondary Metabolites: A Promising Strategy in Combating Parkinson's Disease. Int J Mol Sci 2021;22:12570. [PMID: 34830453 DOI: 10.3390/ijms222212570] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
20 Sen S, Dey A, Maulik U. Studying the effect of alpha-synuclein and Parkinson's disease linked mutants on inter pathway connectivities. Sci Rep 2021;11:16365. [PMID: 34381149 DOI: 10.1038/s41598-021-95889-5] [Reference Citation Analysis]
21 Gallop A, Weagley J, Paracha SU, Grossberg G. The Role of The Gut Microbiome in Parkinson's Disease. J Geriatr Psychiatry Neurol 2021;34:253-62. [PMID: 34219519 DOI: 10.1177/08919887211018268] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
22 Mitsunari K, Miyata Y, Matsuo T, Mukae Y, Otsubo A, Harada J, Kondo T, Matsuda T, Ohba K, Sakai H. Pharmacological Effects and Potential Clinical Usefulness of Polyphenols in Benign Prostatic Hyperplasia. Molecules 2021;26:450. [PMID: 33467066 DOI: 10.3390/molecules26020450] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]